Skip to main content

The Role of the IGF/Insulin-IGFBP Axis in Normal Physiology and Disease

90kviews
Editorial21 April 2022
Editorial: The Role of the IGF/Insulin-IGFBP Axis in Normal Physiology and Disease

Life-Long Health". We discussed cutting-edge research on the fundamental roles of IGF and insulin in normal physiology and diseases particularly related to aging, cancer, and metabolic disorders. IGFs and insulin are conserved throughout evolution to mediate the effects of nutrition on growth, metabolism, and development, and hence play a significant role in health and disease over the lifespan. They modulate diverse aspects of cell function such as proliferation, differentiation, survival, and metabolism of most physiological systems in the body. The IGF family of ligands, receptors, and IGF binding proteins are frequently affected in many pathological conditions, such as growth failure, diabetes, cancer, and degenerative diseases, and therefore have become attractive therapeutic targets. This conference encompassed ground-breaking information regarding critical characteristics of the biology of the IGF/insulin family in both normal physiology and pathological states highlighting innovative methodologies and novel interactions (e.g., stem cell biology and the microbiome). We selected eight exciting topics presented at the GRC for this special issue on "The Role of the research that are necessary for future studies. From C. elegans to rhesus monkeys, it has been reported that suppression of insulin-like activity is associated with an increased life span. Together with other reports from this GRC, excessive induction of insulin-like activity can lead to cancer, and excessive attenuation leads to various diseases that are also problematic in an aging society, such as Alzheimers. These results clearly demonstrate the importance of regulating insulin-like activity to an appropriate range to maintain a lifetime of good health. This regulation is accomplished through ligand production, interaction with binding proteins, receptor expression, and signaling. The future mission of this research area is to elucidate how abnormalities in molecular signalling pathways utilized by the IGF axis correlate with the phenotype associated with pathological conditions, to develop preventive and therapeutic interventions, leading to higher quality resource animals and an increase in healthy life expectancy in humans. The IGFs are clearly relevant to all life phenomena and as such have attracted many researchers to the field from different backgrounds, highlighted by the varied and diverse presentations covering both normal physiology and disease. An IGF focus within a cross-disciplinary approach yields exciting, novel and groundbreaking discoveries that were presented at the GRC, and the participants all shared in the excitement. We are delighted for the broader community to provide a taste of this GRC in this special issue. The next GRC on the IGF and Insulin System in Physiology and Disease will be held in March 2023. We look forward to seeing you all there.IGF

2,007 views

7 citations

Controlled Signaling—Insulin-Like Growth Factor Receptor Endocytosis and Presence at Intracellular Compartments
Ligand-induced activation of the IGF-1 Receptor triggers plasma-membrane-derived signal transduction, but also triggers receptor endocytosis, which was previously thought to limit signaling. However, it is becoming ever more clear that IGF-1R endocytosis and trafficking to specific subcellular locations can define specific signaling responses that are important for key biological processes in normal cells and cancer cells. In different cell types, specific cell adhesion receptors and associated proteins can regulate IGF-1R endocytosis and trafficking. Once internalized, the IGF-1R may be recycled, degraded or translocated to the intracellular membrane compartments of the Golgi apparatus or the nucleus. The IGF-1R is present in the Golgi-apparatus of migratory cancer cells where it signaling contributes to aggressive cancer behaviors including cell migration. The IGF-1R is also found in the nucleus of certain cancer cells where it can regulate gene expression. Nuclear IGF-1R is associated with poor clinical outcomes. IGF-1R signaling has also been shown to support mitochondrial biogenesis and function, and IGF-1R inhibition causes mitochondrial dysfunction. How IGF-1R intracellular trafficking and compartmentalized signaling is controlled is still unknown. This is an important area for further study, particularly in cancer.

11,141 views

47 citations

6,113 views

33 citations

ORIGINAL RESEARCH
2 September 2020
Pregnancy-Associated Plasma Protein-A2 Is Associated With Mortality in Patients With Lung Cancer
Rikke Hjortebjerg, 6 more and Jan Frystyk

3,904 views

10 citations

REVIEW
3 March 2020
Insulin-Like Growth Factor Binding Protein-5 in Physiology and Disease
Cunming Duanand John B. Allard
Insulin-Like Growth Factor Binding Protein-5 in Physiology and Disease
Insulin-like growth factor (IGF) signaling is regulated by a conserved family of IGF binding proteins (IGFBPs) in vertebrates. Among the six distinct types of IGFBPs, IGFBP-5 is the most highly conserved across species and has the broadest range of biological activities. IGFBP-5 is expressed in diverse cell types, and its expression level is regulated by a variety of signaling pathways in different contexts. IGFBP-5 can exert a range of biological actions including prolonging the half-life of IGFs in the circulation, inhibition of IGF signaling by competing with the IGF-1 receptor for ligand binding, concentrating IGFs in certain cells and tissues, and potentiation of IGF signaling by delivery of IGFs to the IGF-1 receptor. IGFBP-5 also has IGF-independent activities and is even detected in the nucleus. Its broad biological activities make IGFBP-5 an excellent representative for understanding IGFBP functions. Despite its evolutionary conservation and numerous biological activities, knockout of IGFBP-5 in mice produced only a negligible phenotype. Recent research has begun to explain this paradox by demonstrating cell type-specific and physiological/pathological context-dependent roles for IGFBP-5. In this review, we survey and discuss what is currently known about IGFBP-5 in normal physiology and human disease. Based on recent in vivo genetic evidence, we suggest that IGFBP-5 is a multifunctional protein with the ability to act as a molecular switch to conditionally regulate IGF signaling.

17,793 views

108 citations

ORIGINAL RESEARCH
28 February 2020
Myoblasts With Higher IRS-1 Levels Are Eliminated From the Normal Cell Layer During Differentiation
Ryosuke Okino, 3 more and Fumihiko Hakuno

4,247 views

4 citations